000 01041 a2200277 4500
005 20250511175206.0
264 0 _c19930401
008 199304s 0 0 eng d
022 _a0284-186X
024 7 _a10.3109/02841869209089719
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOstenstad, B
245 0 0 _aDisodium pamidronate versus mithramycin in the management of tumour-associated hypercalcemia.
_h[electronic resource]
260 _bActa oncologica (Stockholm, Sweden)
_c1992
300 _a861-4 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aDiphosphonates
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aHypercalcemia
_xblood
650 0 4 _aNeoplasms
_xcomplications
650 0 4 _aPamidronate
650 0 4 _aPlicamycin
_xtherapeutic use
700 1 _aAndersen, O K
773 0 _tActa oncologica (Stockholm, Sweden)
_gvol. 31
_gno. 8
_gp. 861-4
856 4 0 _uhttps://doi.org/10.3109/02841869209089719
_zAvailable from publisher's website
999 _c1297163
_d1297163